Hongfeng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hongfeng Chen has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ai-Hua Wang
Key Laboratory of Plant Resources Conservation and Sustainable Utilization, Guangdong Provincial Key Laboratory of Applied Botany, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou 510650, China; Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education, Nanning Normal University, Nanning 530001, China
1 shared publication - Anoop Babu Vasandan
Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
1 shared publication - Balthasar Clemens Schlotmann
Biotech Research & Innovation Centre (BRIC) - University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark
1 shared publication - Ben Youngblood
Department of Immunology, St. Jude Children’s Research Hospital, Memphis, USA
1 shared publication - Caitlin C. Zebley
Department of Immunology, St. Jude Children’s Research Hospital, Memphis, USA
1 shared publication Casey O’cOnnell
Jane Anne Nohl Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 11 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 386 (6718) , eadl4492
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Epigenetic reinforcement of T cell exhaustion is known to be a major barrier limiting T cell responses during immunotherapy. However, the core epigenetic regulators restricting antitumor immunity during prolonged antigen exposure are not clear. We investigated three commonly mutated epigenetic regulators that promote clonal hematopoiesis to determine whether they affect T cell stemness and response to checkpoint blockade immunotherapy. CD8 T cells lacking Dnmt3a, Tet2, or Asxl1 preserved a progenitor-exhausted (Tpex) population for more than 1 year during chronic antigen exposure without undergoing malignant transformation. Asxl1 controlled the self-renewal capacity of T cells and reduced CD8 T cell differentiation through H2AK119 ubiquitination and epigenetic modification of the polycomb group–repressive deubiquitinase pathway. Asxl1-deficient T cells synergized with anti–PD-L1 immunotherapy to improve tumor control in experimental models and conferred a survival advantage to mutated T cells from treated patients.
- 11 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 386 (6718) , eadl4492
Top Cited PapersEpigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Epigenetic reinforcement of T cell exhaustion is known to be a major barrier limiting T cell responses during immunotherapy. However, the core epigenetic regulators restricting antitumor immunity during prolonged antigen exposure are not clear. We investigated three commonly mutated epigenetic regulators that promote clonal hematopoiesis to determine whether they affect T cell stemness and response to checkpoint blockade immunotherapy. CD8 T cells lacking Dnmt3a, Tet2, or Asxl1 preserved a progenitor-exhausted (Tpex) population for more than 1 year during chronic antigen exposure without undergoing malignant transformation. Asxl1 controlled the self-renewal capacity of T cells and reduced CD8 T cell differentiation through H2AK119 ubiquitination and epigenetic modification of the polycomb group–repressive deubiquitinase pathway. Asxl1-deficient T cells synergized with anti–PD-L1 immunotherapy to improve tumor control in experimental models and conferred a survival advantage to mutated T cells from treated patients.
- Open Access
- 1 February 2021
- Published by Taylor & Francis in Mitochondrial DNA Part B
- Vol. 6 (2) , 641-642
The complete chloroplast genome of Plateau herb Chesneya acaulis (Fabaceae)
Chesneya acaulis is a perennial herb, which restricts in Xizang (Tibet) of China, Afghanistan, and Pakistan. The complete chloroplast genome was sequenced using the Illumina Hiseq X-Ten platform. The genome lacks an inverted repeat (IR) region, containing 75 protein-coding genes, 29 tRNAs genes, and 4 rRNAs. The overall GC content is 34.6%. A phylogenetic tree based on the whole chloroplast genomes of 15 species indicated that C. acaulis had a close relationship with the genus Hedysarum, and it nested in the inverted repeat-lacking clade (IRLC), of the subfamily Papilionoideae (Leguminosae).
- 1 February 2021
- Published by Taylor & Francis in Mitochondrial DNA Part B
- Vol. 6 (2) , 641-642
Open AccessThe complete chloroplast genome of Plateau herb Chesneya acaulis (Fabaceae)
Chesneya acaulis is a perennial herb, which restricts in Xizang (Tibet) of China, Afghanistan, and Pakistan. The complete chloroplast genome was sequenced using the Illumina Hiseq X-Ten platform. The genome lacks an inverted repeat (IR) region, containing 75 protein-coding genes, 29 tRNAs genes, and 4 rRNAs. The overall GC content is 34.6%. A phylogenetic tree based on the whole chloroplast genomes of 15 species indicated that C. acaulis had a close relationship with the genus Hedysarum, and it nested in the inverted repeat-lacking clade (IRLC), of the subfamily Papilionoideae (Leguminosae).
- Open Access
- 16 October 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (10) , e1009046
The Ccr4-Not complex regulates TORC1 signaling and mitochondrial metabolism by promoting vacuole V-ATPase activity
The Ccr4-Not complex functions as an effector of multiple signaling pathways that control gene transcription and mRNA turnover. Consequently, Ccr4-Not contributes to a diverse array of processes, which includes a significant role in cell metabolism. Yet a mechanistic understanding of how it contributes to metabolism is lacking. Herein, we provide evidence that Ccr4-Not activates nutrient signaling through the essential target of rapamycin complex 1 (TORC1) pathway. Ccr4-Not disruption reduces global TORC1 signaling, and it also upregulates expression of the cell wall integrity (CWI) pathway terminal kinase Mpk1. Although CWI signaling represses TORC1 signaling, we find that Ccr4-Not loss inhibits TORC1 independently of CWI activation. Instead, we demonstrate that Ccr4-Not promotes the function of the vacuole V-ATPase, which interacts with the Gtr1 GTPase-containing EGO complex to stimulate TORC1 in response to nutrient sufficiency. Bypassing the V-ATPase requirement in TORC1 activation using a constitutively active Gtr1 mutant fully restores TORC1 signaling in Ccr4-Not deficient cells. Transcriptome analysis and functional studies revealed that loss of the Ccr4 subunit activates the TORC1 repressed retrograde signaling pathway to upregulate mitochondrial activity. Blocking this mitochondrial upregulation in Ccr4-Not deficient cells further represses TORC1 signaling, and it causes synergistic deficiencies in mitochondrial-dependent metabolism. These data support a model whereby Ccr4-Not loss impairs V-ATPase dependent TORC1 activation that forces cells to enhance mitochondrial metabolism to sustain a minimal level of TORC1 signaling necessary for cell growth and proliferation. Therefore, Ccr4-Not plays an integral role in nutrient signaling and cell metabolism by promoting V-ATPase dependent TORC1 activation. Eukaryotic cells dynamically control nutrient signaling pathways to regulate metabolism, anabolic growth, and cell proliferation through molecular effectors that remain poorly understood. The Ccr4-Not complex is a multiprotein regulatory factor conserved from yeast to humans that integrates both mRNA degradation and ubiquitin ligase activities. While budding yeast Ccr4-Not represses mitochondrial metabolism to allow normal glycolytic metabolism, how it does so is not clear. Herein, we demonstrate that Ccr4-Not activates nutrient signaling through the conserved target of rapamycin complex 1 (TORC1) pathway by promoting the function of the vacuolar V-ATPase proton pump that acidifies the vacuole and activates TORC1. Ccr4-Not deficient cells exhibit decreased V-ATPase stability, leading to defects in both vacuole acidification and TORC1 signaling. This TORC1 defect causes an adaptive upregulation of mitochondrial metabolism to maintain a minimal level of TORC1 activity. This study defines a previously unknown role for Ccr4-Not as a key activator of a conserved eukaryotic nutrient signaling pathway highly relevant to human health and disease.
- 16 October 2020
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 16 (10) , e1009046
Open AccessThe Ccr4-Not complex regulates TORC1 signaling and mitochondrial metabolism by promoting vacuole V-ATPase activity
The Ccr4-Not complex functions as an effector of multiple signaling pathways that control gene transcription and mRNA turnover. Consequently, Ccr4-Not contributes to a diverse array of processes, which includes a significant role in cell metabolism. Yet a mechanistic understanding of how it contributes to metabolism is lacking. Herein, we provide evidence that Ccr4-Not activates nutrient signaling through the essential target of rapamycin complex 1 (TORC1) pathway. Ccr4-Not disruption reduces global TORC1 signaling, and it also upregulates expression of the cell wall integrity (CWI) pathway terminal kinase Mpk1. Although CWI signaling represses TORC1 signaling, we find that Ccr4-Not loss inhibits TORC1 independently of CWI activation. Instead, we demonstrate that Ccr4-Not promotes the function of the vacuole V-ATPase, which interacts with the Gtr1 GTPase-containing EGO complex to stimulate TORC1 in response to nutrient sufficiency. Bypassing the V-ATPase requirement in TORC1 activation using a constitutively active Gtr1 mutant fully restores TORC1 signaling in Ccr4-Not deficient cells. Transcriptome analysis and functional studies revealed that loss of the Ccr4 subunit activates the TORC1 repressed retrograde signaling pathway to upregulate mitochondrial activity. Blocking this mitochondrial upregulation in Ccr4-Not deficient cells further represses TORC1 signaling, and it causes synergistic deficiencies in mitochondrial-dependent metabolism. These data support a model whereby Ccr4-Not loss impairs V-ATPase dependent TORC1 activation that forces cells to enhance mitochondrial metabolism to sustain a minimal level of TORC1 signaling necessary for cell growth and proliferation. Therefore, Ccr4-Not plays an integral role in nutrient signaling and cell metabolism by promoting V-ATPase dependent TORC1 activation. Eukaryotic cells dynamically control nutrient signaling pathways to regulate metabolism, anabolic growth, and cell proliferation through molecular effectors that remain poorly understood. The Ccr4-Not complex is a multiprotein regulatory factor conserved from yeast to humans that integrates both mRNA degradation and ubiquitin ligase activities. While budding yeast Ccr4-Not represses mitochondrial metabolism to allow normal glycolytic metabolism, how it does so is not clear. Herein, we demonstrate that Ccr4-Not activates nutrient signaling through the conserved target of rapamycin complex 1 (TORC1) pathway by promoting the function of the vacuolar V-ATPase proton pump that acidifies the vacuole and activates TORC1. Ccr4-Not deficient cells exhibit decreased V-ATPase stability, leading to defects in both vacuole acidification and TORC1 signaling. This TORC1 defect causes an adaptive upregulation of mitochondrial metabolism to maintain a minimal level of TORC1 activity. This study defines a previously unknown role for Ccr4-Not as a key activator of a conserved eukaryotic nutrient signaling pathway highly relevant to human health and disease.